ADL Bionatur Solutions

ADL Bionatur Solutions Wins New Fermentation Client With Contract Revenues of EUR 20 Million

ADL Bionatur Solutions Reports Continued Strong Revenue Growth for Third Quarter

Financial results for the first half of 2019: ADL Bionatur Solutions increases revenues by 138% and confirms positive operating results

ADL BIONATUR SOLUTIONS REINFORCES ITS GROWTH STRATEGY WITH A EUR 25 MILLION DEBT FINANCING FROM KARTESIA

ADL BIONATUR SOLUTIONS ENTERS INTO AN INITIAL EUR 13 MILLION STRATEGIC ALLIANCE WITH JAPANESE PHARMA COMPANY

ADL Bionatur Solutions and Amyris Expand Contract to 2020

ADL Bionatur Solutions Increases 2019 Production for a Global Nutrition Company for Additional Revenues of over EUR 2.5 Million

ADL Bionatur Solutions reports strong financial results for the first quarter of 2019

Banco Sabadell gives ADL Bionatur Solutions an upside potential of 78%

Nutricion Center NC and ADL Bionatur Solutions sign a strategic alliance to tackle weight control by rebalancing the gut microbiome

Analyst coverage of ADL Bionatur Solutions initiated by Checkpoint with a target price of EUR 3.20 per share

Edison initiates coverage of ADL Bionatur Solutions forecasting an equity valuation of EUR 2.37 per share with an upside potential of 42%

Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand

Fermentalg and ADL BioPharma announce a majormanufacturing alliance to produce Omega 3 food supplements

ADL Bionatur Solutions Raises EUR 12 million with Institutional Investors